NutraIngredients-USA predicts top industry influences in 2012
The topic that gripped the industry for the second half of 2011 shows no signs of going away. The comment period on the Food and Drug Administration s (FDA) NDI draft guidance closed on December 2, 2011, and now the FDA must wade through 146,000 pages of comments.

FDA faults Invacare s compliance: Production at Elyria headquarters could be suspended due to regulations
ELYRIA Production at Invacare s Elyria headquarters could be suspended pending compliance with Food and Drug Administration regulations, according to Invacare spokeswoman Lara Mahoney.

FDA Warns Consumers About ShoulderFlex Massager
Title: FDA Warns Consumers About ShoulderFlex Massager Category: Health News Created: 12/22/2011 11:01:00 AM Last Editorial Review: 12/22/2011